跳至主要内容
临床试验/CTRI/2024/07/071466
CTRI/2024/07/071466招募中Unknown

SGLT2i, ARNi And Diuretic Use In Patients With Heart FailureWith Preserved And Reduced Ejection Fraction - NI

GSM Institute of Pharmaceutical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age equal to or greater than 18 years old
  • EF lesser than or equal to 40 percent for HFrEF and EF greater than or equal to 50 percent for HFpEF with or without Type-2 diabetes mellitus
  • Initiation of SGLT2i
  • Prescribed a loop diuretic and sacubitril valsartan prior to the initiation of SGLT2i

排除标准

  • Estimated glomerular filtration rate less than 20 mL per min per 1.73 meter square or undergoing dialysis
  • Chronic heart failure persisting for a minimum of 6 months, with an ejection fraction below 25 percent at the commencement of SGLT2 inhibitor therapy
  • Discontinuation of SGLT2 inhibitors
  • Inadequate data in the patient medical records

研究者

发起方
GSM Institute of Pharmaceutical Sciences

相似试验